IP Library Granted Patent US 9,566,454
Granted Patent B2
US 9,566,454 · App. 11/738,682 · Granted Feb 14, 2017

Method and sysem for non-ablative acne treatment and prevention

Inventors: Peter G. Barthe (Phoenix, AZ); Michael H. Slayton (Tempe, AZ); Inder Raj S. Makin (Mesa, AZ)
Assignee: Guided Therapy Systems, LLC
A61N7/02A61B8/4272A61B2017/00747A61B2017/22008A61B2018/00666A61M37/0092A61N7/00A61N2007/0008A61N2007/0078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,566,454
App. No.
11/738,682
Granted
Feb 14, 2017
Kind
B2
Abstract

A method and system for non-ablative acne treatment and prevention is disclosed. The method utilizes ultrasound energy which is targeted at a region of interest to treat existing acne and prevent future acne from forming. The application of ultrasound energy causes numerous physiological effects that treat acne. Some of these physiological effects comprise reducing sebum, increasing perfusion at the region of interest, denaturing proteins at the region of interest, creating an uninhabitable environment at the region of interest, initiating programmed cell death at the region of interest and the initiation of mechanical effects at the region of interest.

Claims (36)

1. A method for treating acne in a skin of a subject, the method comprising:

a) identifying a sebaceous gland in a portion of the skin having the acne with ultrasound imaging; and

b) delivering an ultrasound energy from a transducer probe to the sebaceous gland, the ultrasound energy configured to generate an elevated temperature in the sebaceous gland for a predetermined length of time, wherein the predetermined length of time allows a decrease of sebum and sebum production and does not allow ablation or coagulation of tissue within the sebaceous gland at the elevated temperature to treat existing acne and prevent future acne from developing.

2. The method according to claim 1 , wherein the elevated temperature is in a range of 35° C. to 60° C.

3. The method according to claim 1 , wherein the elevated temperature is greater than 50° C. and the predetermined length of time is greater than five seconds.

4. The method according to claim 1 , wherein the elevated temperature and the predetermined length of time correspond to a thermal dose of less than one second at 56° C.

5. The method according to claim 1 , wherein the sebaceous gland is located at a depth below a surface of the skin in a range of 1 millimeter to 10 millimeters and the ultrasound energy is delivered to the depth.

6. The method according to claim 1 , wherein the ultrasound energy is focused ultrasound energy.

7. The method according to claim 6 , the method further comprising moving a focal depth of the focused ultrasound energy to a different focal depth during the delivering the ultrasound energy of step b).

8. A method for treating acne in a skin of a subject, the method comprising:

a) identifying a pilosebaceous tissue in a portion of the skin having the acne with ultrasound imaging, the pilosebaceous tissue containing at least one bacterium associated with the acne; and

b) delivering an ultrasound energy from a transducer probe to the pilosebaceous tissue, the ultrasound energy configured to generate an elevated temperature in the pilosebaceous tissue for a predetermined length of time, wherein the predetermined length of time initiates programmed cell death in the at least one bacterium and does not allow ablation or coagulation of tissue within the pilosebaceous tissue at the elevated temperature to treat existing acne and prevent future acne from developing.

9. The method according to claim 8 , wherein the elevated temperature is in a range of 35° C. to 60° C.

10. The method according to claim 8 , wherein the elevated temperature is greater than 50° C. and the predetermined length of time is greater than five seconds.

11. The method according to claim 8 , wherein the elevated temperature and the predetermined length of time correspond to a thermal dose of less than one second at 56° C.

12. The method according to claim 8 , wherein the pilosebaceous tissue is located at a depth below a surface of the skin in a range of 1 millimeter to 10 millimeters and the ultrasound energy is delivered to the depth.

13. The method according to claim 8 , wherein the ultrasound energy is focused ultrasound energy.

14. The method according to claim 13 , the method further comprising moving a focal depth of the focused ultrasound energy to a different focal depth during the delivering the ultrasound energy of step b).

15. The method according to claim 8 , wherein the at least one bacterium includes Propionibacterium acnes.

16. A method for treating acne in a skin of a subject, the method comprising:

a) identifying a pilosebaceous tissue in a portion of the skin having the acne with ultrasound imaging;

b) delivering an unfocused ultrasound energy from a transducer probe to the pilosebaceous tissue;

c) sensing, using a sensor configured to sense an amount of ultrasound energy transferred to the pilosebaceous tissue, an amount of the unfocused ultrasound energy transferred to the pilosebaceous tissue; and

d) in response to sensing that the amount of the unfocused ultrasound energy transferred to the pilosebaceous tissue has exceeded a predetermined threshold, stopping the delivering the unfocused ultrasound energy,

wherein the predetermined threshold allows a physiological effect in the pilosebaceous tissue and does not allow ablation and coagulation of tissue within the pilosebaceous tissue to treat existing acne and prevent future acne from developing,

wherein the physiological effect is selected from the group consisting of:

increased blood perfusion;

denaturing of proteins;

inhibition of sebum production; and

programmed cell death.

17. The method of claim 16 , wherein the predetermined threshold corresponds to a temperature in the pilosebaceous tissue of greater than 50° C. for a length of time of more than five seconds.

18. The method of claim 16 , wherein the predetermined threshold corresponds to a thermal dose of less than one second at 56° C.

19. The method of claim 16 , wherein the unfocused ultrasound energy is defocused ultrasound energy.

20. The method of claim 16 , the method further comprising:

e) subsequent to step d), waiting a predetermined length of time to allow a temperature in the pilosebaceous tissue to lower; and

f) repeating steps b), c), and d).

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR IN THE ASSIGNEE FROM GUIDED THERAPY SYSTEMS, INC. TO GUIDED THERAPY SYSTEMS, LLC PREVIOUSLY RECORDED ON REEL 019194 FRAME 0745. ASSIGNOR(S) HEREBY CONFIRMS THE TRANSFER OF RIGHTS FROM THE ASSIGNORS TO THE ASSIGNEES. Recorded Jan 22, 2009
From: BARTHE, PETER G; SLAYTON, MICHAEL H; MAKIN, INDER RAJ S
To: GUIDED THERAPY SYSTEMS, LLC
Reel/Frame 022138/0017 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2007
From: BARTHE, PETER G.; SLAYTON, MICHAEL H.; MAKIN, INDER RAJ S.
To: GUIDED THERAPY SYSTEMS, INC.
Reel/Frame 019194/0745 →
Continuity (2)
Provisional Application 60826039 · Sep 18, 2006
Related Publication 20080294073A1 · Nov 27, 2008